Literature DB >> 29759872

Microbiology of Cardiac Implantable Electronic Device Infections.

Ayman A Hussein1, Yacoub Baghdy1, Oussama M Wazni1, Michael P Brunner1, Ghazal Kabbach1, Mingyuan Shao1, Steven Gordon1, Walid I Saliba1, Bruce L Wilkoff1, Khaldoun G Tarakji2.   

Abstract

OBJECTIVES: This study reports a high-volume tertiary care center experience with the microbiology of cardiac implantable electronic devices (CIED) infections with assessment of temporal trends and profiles of late versus early infections.
BACKGROUND: The rates of CIED infections have been increasing. With changing demographics, patient and device characteristics, prophylactic measures, and the wide use of broad-spectrum antibiotics, there is need for updated contemporary data on the microbiology of CIED infections.
METHODS: The study included 816 consecutive patients with confirmed CIED infections who underwent transvenous lead extraction at our institution between the years 2000 and 2011. Blood cultures were obtained in addition of pocket swabs, pocket capsule, and leads.
RESULTS: Staphylococcal species remained the most common pathogens in CIED infections (68.4%), especially coagulase-negative species (37.6%). Methicillin-resistant staphylococci were the pathogens in 33.8% of all CIED infections and accounted for 49.4% of all staphylococcal infections. Gram-negative pathogens were identified in 8.9% of cases, whereas 13.2% were with negative cultures. CIED infections related to streptococci (2.5%), enterococci (4.2%), anaerobes (1.6%), fungi (0.9%), and mycobacteria species (0.2%) were less common. Of pocket infections, 49.5% occurred more than 1 year after pocket manipulation, and 53.6% of these were related to coagulase-negative staphylococci. In contrast, most endovascular infections were related to Staphylococcus aureus. The proportions of culture negative infections have increased (p < 0.0001).
CONCLUSIONS: The study provides contemporary data on the microbiology of CIED infections. The rates of methicillin resistance seem to be greater than those reported from the preceding decade.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac implantable electronic devices; defibrillator; infection; microbiology; pacemaker; transvenous lead extraction

Year:  2016        PMID: 29759872     DOI: 10.1016/j.jacep.2016.01.019

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  17 in total

Review 1.  Prevention of Cardiac Implantable Electronic Device Infections: Update and Evaluation of the Potential Role for Capsulectomy or the Antibiotic Pouch.

Authors:  Marye J Gleva; Jeanne E Poole
Journal:  J Atr Fibrillation       Date:  2017-02-28

2.  Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis.

Authors:  Carina Blomstrom-Lundqvist; Bozena Ostrowska
Journal:  Europace       Date:  2021-05-25       Impact factor: 5.214

3.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

4.  Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices.

Authors:  Andrew Y Lin; Tatiana Saul; Omar M Aldaas; Florentino Lupercio; Gordon Ho; Travis Pollema; Victor Pretorius; Ulrika Birgersdotter-Green
Journal:  JACC Clin Electrophysiol       Date:  2020-12-24

5.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

6.  Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection.

Authors:  Zerelda Esquer Garrigos; Merit P George; Sarwat Khalil; Prakhar Vijayvargiya; Omar M Abu Saleh; Paul A Friedman; James M Steckelberg; Daniel C DeSimone; Walter R Wilson; Larry M Baddour; M Rizwan Sohail
Journal:  Open Forum Infect Dis       Date:  2019-02-21       Impact factor: 3.835

7.  First-in-man implantation of a gold-coated biventricular defibrillator: Difficult differential diagnosis of metal hypersensitivity reaction vs chronic device infection.

Authors:  Dirk Grosse Meininghaus; Juergen Kruells-Muench; Heidrun Peltroche-Llacsahuanga
Journal:  HeartRhythm Case Rep       Date:  2020-02-19

8.  Clostridioides (Clostridium) difficile Pacemaker Infection.

Authors:  Anna Berkefeld; Fabian K Berger; Barbara C Gärtner; Nina Wantia; Anatol Prinzing; Karl-Ludwig Laugwitz; Dirk H Busch; Kathrin Rothe
Journal:  Open Forum Infect Dis       Date:  2020-10-14       Impact factor: 3.835

9.  Delayed Pacemaker Generator Pocket and Lead Primary Infection Due to Burkholderia Cepacia.

Authors:  Fatma Ben Abid; Hussam Al-Saoub; Faraj Howadi; Ahmed AlBishawi; Maliha Thapur
Journal:  Am J Case Rep       Date:  2017-08-03

10.  Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial.

Authors:  Reece Holbrook; Lucas Higuera; Kael Wherry; Dave Phay; Yu-Cheng Hsieh; Kuo-Hung Lin; Yen-Bin Liu
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.